MAPK3 and breast cancer: In in vitro studies, ALA blocks TGF-beta, HMGB1, ERK1/2, and AKT signaling, leading to the inhibition of epithelial-mesenchymal transition and the sensitization of breast cancer cells to ionizing radiation [28,29].